The goal of this Food and Drug Administration-mandated study is to provide quantitative estimates of the serious risks of misuse, abuse, addiction, overdose, and death associated with long-term use of opioid analgesics for management of chronic pain, among patients prescribed extended-release and long-acting (ER/LA) opioid products. Patients will be recruited and interviewed across several health system sites.